NS Pharma Revenue and Competitors
Estimated Revenue & Valuation
- NS Pharma's estimated annual revenue is currently $27.7M per year.
- NS Pharma's estimated revenue per employee is $201,000
Employee Data
- NS Pharma has 138 Employees.
- NS Pharma grew their employee count by 14% last year.
NS Pharma's People
Name | Title | Email/Phone |
---|---|---|
1 | VP | Reveal Email/Phone |
2 | President | Reveal Email/Phone |
NS Pharma Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is NS Pharma?
NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes. NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-license them to the world. From the world to Japan/Asia, NSP in-license promising drug candidates to the Japanese/Asian Markets. In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies. NSP aims to be an indispensable entity in the healthcare industry in line with the guidelines for action “Challengeâ€, “Speedâ€, and “Investigationâ€.
keywords:N/AN/A
Total Funding
138
Number of Employees
$27.7M
Revenue (est)
14%
Employee Growth %
N/A
Valuation
N/A
Accelerator
NS Pharma News
... the target of Sarepta's $90 million product Vyondys 53 (golodirsen) and privately-held NS Pharma's Viltepso (viltolarsen).
... PLI scheme for the pharmaceutical sector and 55 companies, including Sun Pharmaceutical Industries Ltd (NS: SUN ), Aurobindo Pharma (NS:...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $51.5M | 142 | 8% | N/A |
#2 | $14.1M | 149 | -5% | N/A |
#3 | $44.6M | 150 | 9% | N/A |
#4 | $24.2M | 152 | 1% | N/A |
#5 | $35.1M | 152 | N/A | N/A |